Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to LSTA Full portfolio

Position in LSTA

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$52,839
-$60,717 QoQ
Shares Held
15,541
-31.4% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 31 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Derivatives in LSTA

reported options exposure · as of Dec 31, 2022
CallValue
$5,692
CallShares
2,250
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. LSTA ranks #379 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in LSTA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $52,839 15,541
2026-03-31 $113,556 22,666
2024-12-31 $69,353 23,273
2023-12-31 $38,577 14,131
2023-09-30 $39,765 18,582
2023-06-30 $63,558 17,178
2022-12-31 $5,692 2,250
2022-12-31 $25,507 10,082